Last $11.05 USD
Change Today +0.05 / 0.45%
Volume 45.5K
NKTR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 9:57 AM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Dennis George Maki M.D.

Member of Scientific Advisory Group, Nektar Therapeutics
AgeTotal Calculated CompensationThis person is connected to 60 board members in 4 different organizations across 5 different industries.

See Board Relationships
----

Background*

Dr. Dennis George Maki, M.D. serves as the Head of the Section for Infectious Diseases in the Department of Medicine at University of Wisconsin Medical School. Dr. Maki serves as an Ovid O. Meyer Professor of Medicine, Emeritus - Infectious Diseases at Madison, Wisconsin. Dr. Maki served with the Lawrence Radiation Laboratory in Livermore, California as its Physicist and computer programmer. Dr. Maki served as an Epidemic Intelligence Service Officer at the U.S. Center ...

Read Full Background

Corporate Headquarters*

455 Mission Bay Boulevard South
San Francisco, California 94158

United States

Phone: 415-482-5300
Fax: 415-339-5300

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS
University of Wisconsin - Madison
BS
University of Wisconsin - Madison
PhD
University of Wisconsin Hospital and Clinics

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NKTR:US $11.05 USD +0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Peter William Grant Chief Executive Officer and Executive Director
SkyePharma plc
567.0K GBP
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEKTAR THERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.